• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Lorediplon - Articles and news items


Ergomed and Ferrer complete recruitment for Phase IIa insomnia clinical trial

Industry news / 13 September 2016 / Niamh Louise Marriott, Digital Content Producer

The effects of lorediplon (5 and 10 mg) are being compared to both placebo and zolpidem. The aim of the study is to evaluate the appropriate effective dose of lorediplon, to further characterise its efficacy on sleep maintenance/sleep quality and to evaluate any next day hangover effects in adult patients with insomnia disorder…


Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +